385784-72-5

Upstream product

• 385784-71-4 5-methoxy-4-[3-(4-morpholinyl)propoxy]-2-nitrobenzonitrile 
• 385784-69-0 3-methoxy-4-(3-morpholin-4-ylpropoxy)benzaldehyde 
• 385784-70-3 3-methoxy-4-(3-morpholin-4-ylpropoxy)benzonitrile 
• 7357-67-7 4-(3-chloropropyl)morpholine 
• 121-33-5 vanillin 
• 110-91-8 morpholine 
• 1122661-16-8 2-amino-4-(3-chloropropoxy)-5-methoxybenzonitrile 
• 4421-08-3 3-methoxy-4-hydroxybenzonitrile 
• 210918-52-8 4-(3-chloropropoxy)-3-methoxybenzonitrile 
• 1122661-13-5 4-(3-chloropropoxy)-5-methoxy-2-nitrobenzonitrile 

Downstream Products

• 385780-20-1 ethyl (2-{[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinazolin-4-yl]amino}-1,3-thiazol-4-yl)acetate 
• 385784-82-7 ethyl (2-{[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinazolin-4-yl]amino}-1,3-thiazol-5-yl)acetate 

Relevant academic research and scientific papers

AROMATIC RING FUSED TRIAZINE DERIVATIVES AND USES THEREOF

The invention belongs to pharmaceutical field. The invention relates to the compounds according to Formula I, including their optically active forms, pharmaceutically acceptable salts or hydrates, and the pharmaceutical composition comprising thereof as a

THE AROMATIC RING TRIAZINE DERIVATIVES AND THE USES THEREOF

The invention belongs to pharmaceutical field. The invention relates to the compounds according to Formula I. including their optically active forms, pharmaceutically acceptable salts or hydrates, and the pharmaceutical composition comprising thereof as a

Discovery of novel and potent thiazoloquinazolines as selective Aurora A and B kinase inhibitors

The synthesis of a novel series of quinazolines substituted at C4 by five-membered ring aminoheterocycles is reported. Their in vitro structure-activity relationships versus Aurora A and B serine-threonine kinases is discussed. Our results demonstrate tha